---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-020340"
form_type: "8-K"
ticker: null
cik: "0001213660"
company_name: "BIMI Holdings Inc."
filed_at: "2023-03-15T23:59:59+00:00"
generated_at: "2026-06-18T01:41:48.775563+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BIMI closes acquisition of Phenix Bio for $180K cash and performance-contingent stock

## Summary
- Transaction closed March 15, 2023; seller is Chairman Mr. Fnu Oudom (related party).
- Total consideration: $180,000 cash paid plus up to 5,270,000 shares of common stock.
- 270,000 shares subject to shareholder approval; 5,000,000 shares issuable if Phenix generates ≥$2.5M net profit in 2023.
- Shares issued in reliance on exemption from registration under Section 4(a)(2) of the Securities Act.

## SEC filing metadata
- accession: 0001213900-23-020340
- form_type: 8-K
- cik: 0001213660
- company_name: BIMI Holdings Inc.
- filed_at: 2023-03-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213660/000121390023020340/0001213900-23-020340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213660/000121390023020340/ea175263-8k_bimiinter.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-020340
- JSON: https://secwatch.observer/filing/0001213900-23-020340.json
- Plain text: https://secwatch.observer/filing/0001213900-23-020340.txt

## Key facts
- M&A Transactions
  BIMI Holdings Inc. completed an acquisition involving Mr. Fnu Oudom for $180,000 in cash, plus 5,270,000 shares of the Company’s common stock (closed 2023-03-15).
  - Action: acquisition
  - Counterparty: Mr. Fnu Oudom
  - Consideration: $180,000 in cash, plus 5,270,000 shares of the Company’s common stock
  - Closing: 2023-03-15
  source text: 100% of equity interests in Phenix were transferred to the Company and the closing consideration was paid. The aggregate purchase price for the equity interests in Phenix was $180,000 in cash, which has been paid, plus 5,270,000 shares of the Company’s common stock, of which 270,000 shares shall be issued upon the approval of the issuance by the Company’s
  evidence_url: https://www.sec.gov/Archives/edgar/data/1213660/000121390023020340/0001213900-23-020340-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.